+

WO2009084069A3 - Solution oculaire avec du lycopène organique - Google Patents

Solution oculaire avec du lycopène organique Download PDF

Info

Publication number
WO2009084069A3
WO2009084069A3 PCT/IT2008/000793 IT2008000793W WO2009084069A3 WO 2009084069 A3 WO2009084069 A3 WO 2009084069A3 IT 2008000793 W IT2008000793 W IT 2008000793W WO 2009084069 A3 WO2009084069 A3 WO 2009084069A3
Authority
WO
WIPO (PCT)
Prior art keywords
lycopene
organic
ocular solution
solution
ocular
Prior art date
Application number
PCT/IT2008/000793
Other languages
English (en)
Other versions
WO2009084069A4 (fr
WO2009084069A2 (fr
Inventor
Leonardo Rescio
Original Assignee
Lio Farmaceutici Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lio Farmaceutici Srl filed Critical Lio Farmaceutici Srl
Publication of WO2009084069A2 publication Critical patent/WO2009084069A2/fr
Publication of WO2009084069A3 publication Critical patent/WO2009084069A3/fr
Publication of WO2009084069A4 publication Critical patent/WO2009084069A4/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne une solution oculaire topique comportant des caroténoïdes, des liposomes, des lipides végétaux /cérasomes, des phospholipides et des agents de viscosité.
PCT/IT2008/000793 2008-01-02 2008-12-23 Solution oculaire avec du lycopène organique WO2009084069A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000003A ITMI20080003A1 (it) 2008-01-02 2008-01-02 Composizioni per uso oftalmico
ITMI2008A000003 2008-01-02

Publications (3)

Publication Number Publication Date
WO2009084069A2 WO2009084069A2 (fr) 2009-07-09
WO2009084069A3 true WO2009084069A3 (fr) 2009-09-17
WO2009084069A4 WO2009084069A4 (fr) 2009-11-05

Family

ID=40290036

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IT2008/000793 WO2009084069A2 (fr) 2008-01-02 2008-12-23 Solution oculaire avec du lycopène organique

Country Status (2)

Country Link
IT (1) ITMI20080003A1 (fr)
WO (1) WO2009084069A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107106627A (zh) * 2014-10-10 2017-08-29 彼得·F·卡罗 抗氧化眼药水
CN107249678B (zh) * 2014-12-19 2021-02-19 凯敏工业公司 使用离子电渗法进行生物活性分子的眼内递送

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1005154A2 (pt) * 2009-01-19 2018-02-06 Lycored Ltd "composição terapêutica, método para inibir ou reduzir a produção de íons superóxido, óxido nítrico (no), fator necrose tumoral alfa (tnf-alfa) e/ou prostaglandina e2 (pge2) em um indivíduo mamífero, métodos de tratamento e uso de uma combinação"
WO2010096558A1 (fr) 2009-02-18 2010-08-26 Eyeon Particle Sciences Llc Utilisation d'un copolymère bifonctionnel pour des applications ophtalmiques et autres topiques et locales
WO2011138228A1 (fr) * 2010-05-04 2011-11-10 Trb Chemedica Ag Composition aqueuse pour utilisation ophtalmique ou cutanée
ITMI20110849A1 (it) * 2011-05-13 2012-11-14 Farmila Thea Farmaceutici Spa Preparazioni oftalmiche in forma di collirio e loro uso
JP6131269B2 (ja) * 2011-12-21 2017-05-17 ノバルティス アーゲー カロテノイドを含有するコンタクトレンズ及びその製造方法
CA3029391C (fr) 2016-07-06 2024-01-02 Eyeon Particle Sciences Llc Utilisation d'un copolymere bi-fonctionnel pour des applications ophtalmiques.
TW202027733A (zh) * 2019-01-16 2020-08-01 臺北醫學大學 含有葉黃素之點眼液組合物
US11754753B2 (en) * 2020-04-27 2023-09-12 Coopervision International Limited Antioxidant contact lens
RU2745124C1 (ru) * 2020-07-02 2021-03-22 Общество с ограниченной ответственностью "МедикалСайнс" Биоактивная композиция на основе сшитой соли гиалуроновой кислоты, содержащая ресвератрол, и способ ее получения
IT202100006839A1 (it) * 2021-03-22 2022-09-22 Omisan Farm S R L Preparato topico oftalmico idrosolubile contenente luteina e relativo metodo di produzione
EP4218717A1 (fr) 2022-02-01 2023-08-02 Laboratoires THEA Composition ophtalmique comprenant du resvératrol pour traiter le syndrome de l' il sec

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989001772A1 (fr) * 1987-09-03 1989-03-09 University Of Georgia Research Foundation, Inc. Composition de cyclosporine oculaire
US5596011A (en) * 1995-04-06 1997-01-21 Repine; Karen M. Method for the treatment of macular degeneration
US6573299B1 (en) * 1999-09-20 2003-06-03 Advanced Medical Instruments Method and compositions for treatment of the aging eye
US20050065091A1 (en) * 2003-09-18 2005-03-24 Gholam Peyman Stabilized ocular solutions
FR2895257A1 (fr) * 2005-12-22 2007-06-29 Oreal Actif pour le traitement du contour des yeux.

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989001772A1 (fr) * 1987-09-03 1989-03-09 University Of Georgia Research Foundation, Inc. Composition de cyclosporine oculaire
US5596011A (en) * 1995-04-06 1997-01-21 Repine; Karen M. Method for the treatment of macular degeneration
US6573299B1 (en) * 1999-09-20 2003-06-03 Advanced Medical Instruments Method and compositions for treatment of the aging eye
US20050065091A1 (en) * 2003-09-18 2005-03-24 Gholam Peyman Stabilized ocular solutions
FR2895257A1 (fr) * 2005-12-22 2007-06-29 Oreal Actif pour le traitement du contour des yeux.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KRINSKY N I ET AL: "Carotenoid actions and their relation to health and disease", MOLECULAR ASPECTS OF MEDICINE, PERGAMON PRESS, OXFORD, GB, vol. 26, no. 6, 1 December 2005 (2005-12-01), pages 459 - 516, XP025272605, ISSN: 0098-2997, [retrieved on 20051201] *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107106627A (zh) * 2014-10-10 2017-08-29 彼得·F·卡罗 抗氧化眼药水
CN107249678B (zh) * 2014-12-19 2021-02-19 凯敏工业公司 使用离子电渗法进行生物活性分子的眼内递送

Also Published As

Publication number Publication date
ITMI20080003A1 (it) 2009-07-03
WO2009084069A4 (fr) 2009-11-05
WO2009084069A2 (fr) 2009-07-09

Similar Documents

Publication Publication Date Title
WO2009084069A3 (fr) Solution oculaire avec du lycopène organique
USD680153S1 (en) Spectacles
USD691625S1 (en) Portion of a display panel with a user interface component
WO2012100097A3 (fr) Compositions topiques de minocycline et leurs procédés d'utilisation
CA145514S (en) Pump
WO2014015251A3 (fr) Pompes et valves fabriquées à partir de tissu et leurs utilisations
WO2011110275A3 (fr) Fibres rayonnantes
KR20180085042A (ko) 농업, 산업 및 다른 용도를 위한 방부제로서 비스무트-티올
WO2011008570A3 (fr) Tensioactifs de type sulfonate et leurs procédés de préparation et utilisation
USD710864S1 (en) Portion of a display panel with a user interface component
PT2433640T (pt) Composição compreendendo sod, luteína e zeaxantina
USD703223S1 (en) Portion of a display panel with a user interface component
HK1134258A1 (en) Dehydrated liposome formulation
CA140663S (en) Solar panel mount
EP2281932B8 (fr) Câblé d'aramide et procédé de fabrication correspondant
WO2011159982A3 (fr) Photomètre à longueurs d'onde multiples à source de lumière dispersée
WO2013015579A3 (fr) Matériau composite organique médical comprenant du collagène et des dérivés d'acide hyaluronique
USD664497S1 (en) Tire
EP2614256A4 (fr) Pompe à haute pression comprenant un goujon creux
EP2704590B8 (fr) Compositions comportant un anti-métabolite du glucose, bha et/ou bht
WO2011042902A3 (fr) Microcapsules comprenant du peroxyde de benzoyle et compositions topiques comprenant celles-ci
WO2011140525A3 (fr) Procédés et compositions relatifs à la voie sélective des récepteurs aux rétinoïdes
EP2714395A4 (fr) Stratifié résistant à la lumière ultraviolette, et procédé de fabrication correspondant
WO2012160549A3 (fr) Thérapie par biorésonance
WO2012125468A3 (fr) Traitements de semences améliorés au moyen d'huiles

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

WPC Withdrawal of priority claims after completion of the technical preparations for international publication

Ref document number: MI2008A000003

Country of ref document: IT

Date of ref document: 20100701

Free format text: WITHDRAWN AFTER TECHNICAL PREPARATION FINISHED

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08868584

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 08868584

Country of ref document: EP

Kind code of ref document: A2

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载